Antimicrobial Agents and Chemotherapy, September 1998, p. 2319-2325, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
-Lactamases
Microbiologie Moléculaire et
Génie des Protéines,
Received 24 June 1997/Returned for modification 12 October
1997/Accepted 30 June 1998
Class A
-lactamases are inactivated by the suicide
inactivators sulbactam, clavulanic acid, and tazobactam. An examination of multiple alignments indicated that amino acids 216 to 218 differed among class A enzymes. By random replacement mutagenesis of codons 216 to 218 in PSE-4, a complete library consisting of 40,864 mutants was
created. The library of mutants with mutations at positions 216 to 218 in PSE-4 was screened on carbenicillin and ampicillin with the
inactivator sulbactam; a collection of 14 mutants was selected, and
their bla genes were completely sequenced. Purified wild-type and mutant PSE-4
-lactamases were used to
measure kinetic parameters. One enzyme, V216S:T217A:G218R, was examined
for its peculiar pattern of inhibition. There was an increase in the
Km from 68 µM for the wild type to 271 µM
for the mutant for carbenicillin and 33 to 216 µM for ampicillin.
Relative to the wild-type PSE-4 enzyme, 37- and 30-fold increases in
Ki values were observed for the mutant enzyme
for sulbactam and tazobactam, respectively. The results that were
obtained suggested that positions 216 to 218 are important for
interactions with penicillanic acid sulfone inhibitors. In contrast,
V216 and A217 in the TEM-1 class A
-lactamase do not
tolerate amino acid residue substitutions. However, for the PSE-4
-lactamase, 11 of 14 mutants from the library of mutants with mutations at positions 216 to 218 whose sequences were determined had substitutions at position 216 (G, R, A, S) and position 217 (A, S).
The data showed the importance of residues 216 to 218 in their atomic
interactions with inactivators in the PSE-4
-lactamase structure.
*
Corresponding author. Mailing address: Microbiologie
Moléculaire et Génie des Protéines, Science de la Vie
et de la Santé, Faculté de Médecine, Pavillon
Charles-Eugène Marchand, Université Laval, Ste-Foy,
Québec, Canada G1K 7P4. Phone: (418) 656-3070. Fax: (418)
656-7176. E-mail: rclevesq{at}rsvs.ulaval.ca.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |